Assets/BlogsEU CTR Challenges Sponsors and CROs To Get Their...

EU CTR Challenges Sponsors and CROs To Get Their Houses in Order

-

The Clinical Trials Regulation1 represents a milestone on the journey to a more competitive European R&D environment, particularly for multinational studies. Improved trial transparency — and EMA has recently opened a public consultation in this area — will make it easier for patients to participate in research. A harmonized approach to clinical trial applications across Europe should lead to faster approvals.

However, companies have been facing challenges in several areas since EU CTR became mandatory three months ago. Sponsors and contract research organizations (CROs) find it difficult to coordinate submissions cross-functionally and meet tight deadlines, partly due to fragmented and time-consuming data collection. Redactions are another sticking point. Disclosures must be fully integrated within the standard clinical trial process yet occur more frequently across the trial lifecycle than before.

eu-ctr-challenges-sponsors-and-cros-to-get-their-houses-in-order

Latest Whitepapers

Mastering the Art of B2B Content Distribution

In the realm of B2B content marketing, creating high-quality content is only half the battle. To truly succeed, businesses...

Effective Lead Nurturing

For success in today’s digital marketing age, advanced lead nurturing through social media content is essential. It must focus...

Harnessing Potential of Email Marketing for B2B Success

Email marketing is a long-term strategy that requires consistent effort and adaptation to achieve B2B success. Below are 20...

Must read

Effective Lead Nurturing

For success in today’s digital marketing age, advanced lead...

Harnessing Potential of Email Marketing for B2B Success

Email marketing is a long-term strategy that requires consistent...

Newsletter

You might also likeRELATED
Recommended to you